Synergism between the mTOR inhibitor rapamycin and FAK down-regulation in the treatment of acute lymphoblastic leukemia
Crossref DOI link: https://doi.org/10.1186/s13045-016-0241-x
Published Online: 2016-02-18
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Shi, Pei-Jie
Xu, Lu-Hong
Lin, Kang-Yu
Weng, Wen-jun
Fang, Jian-Pei
Funding for this research was provided by:
National Natural Science Foundation of China (81100370)
National Natural Science Foundation of China (81570140)
